leisure time -WSS

leisure time

author：explore 2025-09-28 01:36:11 - browse：3

The US Supreme Court silhouetted -- Abortion coverage from STAT — STEFANI REYNOLDS/AFP via Getty Images

WASHINGTON — The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

The justices seemed by turns relucant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers.

The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. The Sacklers would contribute up to $6 billion and give up ownership of the company, but retain billions more. The company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

knowledge

WSS

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

NIH nominee Bertagnolli will get October confirmation hearing

How a scoliosis diagnosis changed the life of one young dancer

Humana sues Biden admin over Medicare Advantage audit rule

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

JPM: CVS says Medicare Advantage patients are impacting profits

explore

leisure time

explore

New air purifier tech could be key to improving indoor air quality

Humana sues Biden admin over Medicare Advantage audit rule

State Dept. review finds Biden bears some blame for Afghanistan failures

Videos point to link between seizures and unexplained toddler deaths

ChatGPT in medicine: STAT answers readers' burning questions

'Make People Better': The CRISPR babies story you probably don't know

Trump demands the U.S. pay no more for drugs than other countries … again

Illumina names Agilent executive as new CEO

23andMe had bad news about my health. I wish a person had delivered it

Snackable artificial intelligence, expert AI, and the pharma industry

leisure time

Medicaid rebukes states for mistakenly disenrolling children

GSK Flovent asthma inhalers replaced by authorized generics

U.K. sequencing study surfaces new findings about tumor DNA

Stem cell treatment guidelines are released by FDA

NIH nominee Bertagnolli will get October confirmation hearing

GSK Flovent asthma inhalers replaced by authorized generics

hotspot

knowledge

focus

focus